RPS29 is a structural component of the small 40S ribosomal subunit essential for protein synthesis and ribosome biogenesis 1. The protein functions in rRNA processing and maintains accurate ribosomal translation in cells 12. RPS29 also contains zinc-binding capacity and localizes to the cytoplasm, endoplasmic reticulum, and nucleoplasm where it contributes to translation regulation. Germ-line mutations in RPS29 cause Diamond-Blackfan anemia (DBA-13), a cancer-prone inherited bone marrow failure syndrome affecting erythroid differentiation 1. Two distinct mutations (p.I31F and p.I50T) identified in DBA families result in haploinsufficiency and defective pre-rRNA processing, leading to erythropoiesis failure in zebrafish models 13. The RPS29-dependent p53 pathway appears central to DBA pathophysiology, with calmodulin inhibitors showing therapeutic promise by attenuating p53 activity in patient cells 3. Beyond DBA, RPS29 downregulation occurs in amyotrophic lateral sclerosis motor neurons, where it suppresses pathological protein translation and maintains levels of the essential neuronal protein STMN2, suggesting a quality control role 2. RPS29 transcription is also directly targeted for suppression by the tumor suppressor POGK in triple-negative breast cancer, contributing to growth inhibition 4. These findings establish RPS29 as a critical ribosomal protein with disease relevance spanning hematologic, neurologic, and malignant conditions.